tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Elmar Kraus, 7 are a BUY (53.85%), 6 are a HOLD (46.15%).
Analyst Elmar Kraus, currently employed at DZ BANK, carries an average stock price target met ratio of 80% that have a potential upside of 13.42% achieved within 298 days.
Elmar Kraus’s has documented 26 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LLY, Eli Lilly and Company at 21-Feb-2024.
Analyst best performing recommendations are on BIIB (BIOGEN).
The best stock recommendation documented was for LLY (ELI LILLY AND COMPANY) at 1/21/2022. The price target of $291 was fulfilled within 75 days with a profit of $54.35 (22.97%) receiving and performance score of 3.06.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$165
$24.45 (17.40%)
$225
11 days ago
(10-Jan-2025)
9/16 (56.25%)
$16.98 (11.47%)
225
Buy
$138
$-2.55 (-1.81%)
$313
19 days ago
(02-Jan-2025)
32/46 (69.57%)
$-15.62 (-10.17%)
418
Buy
$164
$23.45 (16.68%)
$230
1 months 1 days ago
(20-Dec-2024)
18/25 (72%)
$16.61 (11.27%)
215
Buy
$175
$34.45 (24.51%)
$287
1 months 5 days ago
(16-Dec-2024)
15/25 (60%)
$23.59 (15.58%)
215
Hold
$178
$37.45 (26.65%)
$190
1 months 11 days ago
(10-Dec-2024)
12/20 (60%)
$22.15 (14.21%)
180
What Year was the first public recommendation made by Elmar Kraus?
